Thrombogenics, Inc. is a company that provides Biotechnology, Diabetic Eye Disease, Biopharmaceutical and more. Thrombogenics, Inc. is headquartered in United States New York. Thrombogenics, Inc. has a total of 149 patents
Thrombogenics, Inc., a subsidiary of Oxurion NV, is a company headquartered in New York, NY. The firm operates as a biotechnology company engages in delivering...